CSDTI: an interpretable cross-attention network with GNN-based drug molecule aggregation for drug-target interaction prediction

被引:5
作者
Pan, Yaohua [1 ]
Zhang, Yijia [1 ]
Zhang, Jing [1 ]
Lu, Mingyu [1 ]
机构
[1] Dalian Maritime Univ, Sch Informat Sci & Technol, Dalian 116026, Liaoning, Peoples R China
关键词
Drug discovery; Interpretability analysis; Cross-Attention network; Drug-target interaction; IDENTIFICATION; OPTIMIZATION; DISCOVERY; DOCKING; RHEIN;
D O I
10.1007/s10489-023-04977-8
中图分类号
TP18 [人工智能理论];
学科分类号
081104 ; 0812 ; 0835 ; 1405 ;
摘要
Drug-target interaction (DTI) is a critical and complex process that plays a vital role in drug discovery and design. In deep learning-based DTI methods, graph neural networks (GNNs) are employed for drug molecule modeling, attention mechanisms are utilized to simulate the interaction between drugs and targets. However, existing methods still face two limitations in these aspects. First, GNN primarily focus on local neighboring nodes, making it difficult to capture the global 3D structure and edge information. Second, the current attention-based methods for modeling drug-target interactions lack interpretability and do not fully utilize the deep representations of drugs and targets. To address the aforementioned issues, we propose an interpretable network architecture called CSDTI. It utilizes a cross-attention mechanism to capture the interaction features between drugs and targets. Meanwhile, we design a drug molecule aggregator to capture high-order dependencies within the drug molecular graph. These features are then utilized simultaneously for downstream tasks. Through rigorous experiments, we have demonstrated that CSDTI outperforms state-of-the-art methods in terms of performance metrics such as AUC, precision, and recall in DTI prediction tasks. Furthermore, the visualization mapping of attention weights indicates that CSDTI can provide chemical insights even without external knowledge.
引用
收藏
页码:27177 / 27190
页数:14
相关论文
共 47 条
  • [1] Unified rational protein engineering with sequence-based deep representation learning
    Alley, Ethan C.
    Khimulya, Grigory
    Biswas, Surojit
    AlQuraishi, Mohammed
    Church, George M.
    [J]. NATURE METHODS, 2019, 16 (12) : 1315 - +
  • [2] Bottom-Up and Top-Down Attention for Image Captioning and Visual Question Answering
    Anderson, Peter
    He, Xiaodong
    Buehler, Chris
    Teney, Damien
    Johnson, Mark
    Gould, Stephen
    Zhang, Lei
    [J]. 2018 IEEE/CVF CONFERENCE ON COMPUTER VISION AND PATTERN RECOGNITION (CVPR), 2018, : 6077 - 6086
  • [3] An open source chemical structure curation pipeline using RDKit
    Bento, A. Patricia
    Hersey, Anne
    Felix, Eloy
    Landrum, Greg
    Gaulton, Anna
    Atkinson, Francis
    Bellis, Louisa J.
    De Veij, Marleen
    Leach, Andrew R.
    [J]. JOURNAL OF CHEMINFORMATICS, 2020, 12 (01)
  • [4] TransformerCPI: improving compound-protein interaction prediction by sequence-based deep learning with self-attention mechanism and label reversal experiments
    Chen, Lifan
    Tan, Xiaoqin
    Wang, Dingyan
    Zhong, Feisheng
    Liu, Xiaohong
    Yang, Tianbiao
    Luo, Xiaomin
    Chen, Kaixian
    Jiang, Hualiang
    Zheng, Mingyue
    [J]. BIOINFORMATICS, 2020, 36 (16) : 4406 - 4414
  • [5] TTD: Therapeutic Target Database
    Chen, X
    Ji, ZL
    Chen, YZ
    [J]. NUCLEIC ACIDS RESEARCH, 2002, 30 (01) : 412 - 415
  • [6] Drug-Target Interaction Prediction Using Multi-Head Self-Attention and Graph Attention Network
    Cheng, Zhongjian
    Yan, Cheng
    Wu, Fang-Xiang
    Wang, Jianxin
    [J]. IEEE-ACM TRANSACTIONS ON COMPUTATIONAL BIOLOGY AND BIOINFORMATICS, 2022, 19 (04) : 2208 - 2218
  • [7] Dauphin YN, 2017, PR MACH LEARN RES, V70
  • [8] Comprehensive analysis of kinase inhibitor selectivity
    Davis, Mindy I.
    Hunt, Jeremy P.
    Herrgard, Sanna
    Ciceri, Pietro
    Wodicka, Lisa M.
    Pallares, Gabriel
    Hocker, Michael
    Treiber, Daniel K.
    Zarrinkar, Patrick P.
    [J]. NATURE BIOTECHNOLOGY, 2011, 29 (11) : 1046 - U124
  • [9] Key factors in the rising cost of new drug discovery and development
    Dickson, M
    Gagnon, JP
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2004, 3 (05) : 417 - 429
  • [10] L-dihydroxyphenylserine (L-DOPS): A norepinephrine prodrug
    Goldstein, David S.
    [J]. CARDIOVASCULAR DRUG REVIEWS, 2006, 24 (3-4): : 189 - 203